Fundraising Fox
Biocomposites
Keele, GB · Founded 1997 · 383 employees on LinkedIn · 3 known investors
Find your way into Biocomposites
Sign up to see every warm intro you have to Biocomposites
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biocomposites team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biocomposites develops and manufactures calcium-based and medical-grade polymer composite devices used in orthopaedic surgery, including products designed for use in the presence of infection. Founded via a management buyout of a ceramics company, it manufactures around one million units annually and sells to 100 countries.
Investors · 3
How we know: Adams Street Partners's portfolio page · Not right? Tell us
How we know: TA Associates's portfolio page · funding news · press coverage · Not right? Tell us
How we know: funding news · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- BIOCOMPOSITES LIMITED
- Company number
- 03291943
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 13 Dec 1996
- Registered office
- C/O Biocomposites Limited Keele Science Park, Keele, Newcastle, Staffs, ST5 5NL
- Nature of business (SIC)
- 32500 — Manufacture of medical and dental instruments and supplies
- Previous names
- GRINDCO 114 LIMITED (1996–1997)
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 13 Dec 2025 · next due 27 Dec 2026
Current officers · 8
- Sean Sydney Aiken — director, appointed 14 Nov 2014
- Ciara Mary Elizabeth Airey — director, appointed 18 Jul 2023
- Simon George Greenhalgh — director, appointed 26 Apr 2022
- Michael Christopher James Harris — director, appointed 11 Jul 2019
- Phillip Anthony Laycock — director, appointed 28 Jun 2017
- Jonathan Michael Edmund Mahoney — director, appointed 6 Sept 2013
- Peter Webster — director, appointed 6 Jul 2022
- Hamish Morrison White — director, appointed 6 Sept 2013
Source: Companies House public register · retrieved 20 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Biocomposites do?
- Biocomposites develops and manufactures calcium-based and medical-grade polymer composite devices used in orthopaedic surgery, including products designed for use in the presence of infection. Founded via a management buyout of a ceramics company, it manufactures around one million units annually and sells to 100 countries.
- Who are Biocomposites's investors?
- Biocomposites's investors include Adams Street Partners, TA Associates, Barings BDC.
- Where is Biocomposites headquartered?
- Biocomposites is headquartered in Keele, GB.